<DOC>
	<DOCNO>NCT02620579</DOCNO>
	<brief_summary>Chronic shoulder pain common , costly , disable problem society . The identification factor predictive development chronic shoulder pain necessary develop innovative effective treatment reduce societal impact shoulder disorder . In previous work investigator identify genetic psychological subgroup robustly predict heighten shoulder pain response pre-clinical cohort poor 12 month shoulder pain recovery rate clinical surgical cohort . In follow-up study investigator propose test intervention tailor high risk subgroup affect pain response pre-clinical cohort . The optimal theorized match identify high-risk subgroup combination personalize pharmaceutical education intervention . This combined personalized intervention versus placebo pharmaceutical general education intervention group primary comparison interest . Also , evaluation individual effect personalize pharmaceutical educational intervention part study . Such comparison provide important information active portion combine personalize intervention may .</brief_summary>
	<brief_title>Biopsychosocial Influence Shoulder Pain</brief_title>
	<detailed_description>Potential subject screen meet high-risk criterion base COMT genotype high pain sensitivity pain catastrophizing questionnaire score eligible randomization intervention group ( stratify sex ) . Exercise induce shoulder injury serve pain generate mechanism Day 1 participant receive pharmaceutical education intervention Days 1-4 , Days 2-4 respectively . Statistical analysis determine whether combine personalized intervention group experience short shoulder pain duration , low peak pain intensity , decrease upper-extremity disability determine molecular , psychological , pain sensitivity regulation mechanism associate pain relief . A preliminary analysis plan first 300 subject equally randomize 4 intervention group . The comparison interest preliminary analysis combine personalized intervention group placebo general education group primary outcome . Depending result preliminary analysis randomization pattern may change , detail change available protocol paper .</detailed_description>
	<mesh_term>Shoulder Pain</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>English speaking chronic pain ( &gt; 3 month ) area , currently experience neck shoulder pain , previous history neck shoulder pain ( operationally define experience neck shoulder pain longer 48 hour seek medical treatment neck shoulder pain ) , neurological impairment upperextremity ( determined loss sensation , muscle weakness , reflex change ) , regular participation upperextremity weight training , currently regular use pain medication , previous history upperextremity surgery . Additional exclusion criterion propranolol administration report history presence follow cardiovascular condition : clinically significant abnormal 12lead ECG , sinus bradycardia ( rest heart rate 55 beat per minute ) , great first degree heart block , cardiac failure , coronary artery disease , uncontrolled hypertension ( rest systolic blood pressure 140 mm Hg ) , hypotension ( rest systolic blood pressure 90 mm Hg ) , WolffParkinsonWhite syndrome . Noncardiovascular reason study exclusion include : bronchial asthma , nonallergic bronchospasm , history recent major surgery require general anesthesia , diabetes , pregnancy , major depression .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Personalized Pharmaceutical</keyword>
	<keyword>Personalized Education</keyword>
</DOC>